ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #379Top JournalHybrid

Cancer Research

Abbreviation (ISO):CANCER RES
•
Identifier (ISSN):0008-5472(Print)/1538-7445(Online)
•
Publisher:American Association for Cancer Research Inc.
Clarivate IF (2026)
22.6↑ +6
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Cancer Research

WoS Q1
51321299.1320188.3820199.73202012.7202113.3202211.2202312.5202416.6202522.62026
Annual Impact Factor Metric
Current (2026):22.6
Scopus SJR & RankScopus Q1
4.347
#379

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
522

522 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate0.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
492articles/year
35.17% Gold OA•89.57% Original Research

Aims & Scope

Cancer Research is the most frequently cited cancer journal in the world. The journal publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience spanning basic, preclinical, clinical, prevention and epidemiological research. Cancer Research seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer. The main scope of the Journal is captured in its primary subsections, which focus on molecular and cellular pathobiology, tumor and stem cell biology, therapeutics and targets, microenvironment and immunology, prevention and epidemiology, and integrated systems and technology.

Topics Covered (Recognized by AI)
Biology98.8%Genetics97%Medicine96.4%Internal medicine89.8%Chemistry82.5%Biochemistry79.6%Cancer70.8%Cancer research60.9%Gene52.3%Pathology39.1%Immunology34.7%Cell biology31.6%Oncology24.2%Surgery22.3%Breast cancer21.8%Organic chemistry21.8%Endocrinology21.5%Apoptosis21%Cell culture20.6%In vitro20.3%Physics20.2%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q1
Rank16/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q1
Rank22/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF22.6
Articles / Year8,679
Total Citations494
2025
IF16.6
Articles / Year8,266
Total Citations4,798
2024
IF12.5
Articles / Year11,114
Total Citations11,503
2023
IF11.2
Articles / Year8,734
Total Citations18,167
2022
IF13.312
Articles / Year7,739
Total Citations21,026

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #379Scopus Q1SCImago Profile
Scopus Coverage:1941-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
4.347

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
11.16

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,205 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations11,313
3-Year Documents1,065
Citable Documents1,033

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate42.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1
OncologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
1区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cancer Research (abbr: CANCER RES, ISSN: 0008-5472) is a peer-reviewed international scholarly journal in the field of Medicine, published by American Association for Cancer Research Inc. in United States since 1941. The periodical holds a Journal Impact Factor (JIF) of 22.6, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 4.347 (Q1), an H-index of 522.

The journal enforces rigorous peer evaluation with a publication frequency of Semimonthly, an annual output of approximately 492 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $4,205 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
American Association for Cancer Research Inc.
Publication Language
English
Frequency
Semimonthly
Founding Year
1941
Indexing & Databases
SCIEScopusPubMed
Editorial Address
AMER ASSOC CANCER RESEARCH, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 92176c78-97a9-4c50-b484-2ad6974bbe26
Database Updated: 2026-10-01